Improving patient access and the challenges to overcome – Leslie Galloway

Return to the Spotlight: rare diseases and innovative therapies programme Learning objectives  Why treat rare diseases? MHRA's processes for accelerating access to treatments NICE’s approach to rare disease therapies Broader healthcare system challenges for patient access to new medicines Speaker biography Leslie has built a successful career of over 45 years in senior management roles, both in the pharmaceutical and medical device industries, which culminated in the successful turnaround of a pharmaceutical business. He was elected as Chairman of EMIG in 2005 and has been instrumental in its metamorphosis from its origins as a business and networking group to the...